Floatz logo

Colloidal Gold-Bound Tumor Necrosis Factor

Adrenocortical Carcinoma

National Institutes of Health Clinical Center (CC)Early Phase 1Dormant
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
89/ 100

Competitive context

22 Active assets in the Adrenocortical Carcinoma cohort.

Asset / SponsorPhaseRating
CIS-DIAMMINEDICHLOROPLATINUM II
Vanderbilt-Ingram Cancer Center
Phase 2BB
Inno-206
National Cancer Institute (NCI)
Phase 2BB
Cyclophosphamide
Anusha Kalbasi
Phase 2B
Nivolumab
Dana-Farber Cancer Institute
Phase 2B
Pembrolizumab
Corcept Therapeutics
Phase 2B

View all 43 →

Same molecule, other indications

Colloidal Gold-Bound Tumor Necrosis Factor is also rated in:

cancer of unknown primary siteDormant
CC
Indicative ·
46 / 100
View asset →
digestive system cancerDormant
CC
Indicative ·
41 / 100
View asset →
cutaneous melanomaDormant
CC
Indicative ·
41 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →